SIRPα on Mouse B1 Cells Restricts Lymphoid Tissue Migration and Natural Antibody Production

Area of Science:

• Immunology
• Cell Biology
• Cardiovascular Research

Background:

• The CD47-SIRPα axis is a critical innate immune checkpoint, with therapeutic potential in oncology.
• SIRPα (Signal regulatory protein alpha) is typically found on myeloid and neuronal cells.
• B1 lymphocytes produce natural antibodies and play roles in innate immunity and autoimmunity.

Purpose of the Study:

• To investigate the expression and function of SIRPα on B1 lymphocytes.
• To determine the role of SIRPα signaling in B1 cell migration and natural antibody production.
• To explore the impact of SIRPα signaling on atherosclerosis development.

Main Methods:

• Analysis of SIRPα expression on murine B1 lymphocytes.
• Studies using SIRPα signaling-deficient mice (SIRPα^ΔCYT) and bone marrow chimeras.
• Assessment of B1 cell migration, antibody levels, and atherosclerosis in experimental models.

Main Results:

• SIRPα is expressed on B1 lymphocytes, regulating their migration and natural antibody production.
• SIRPα-deficient mice exhibit increased B1 cell migration and elevated natural antibody levels.
• Targeting SIRPα signaling in atherosclerosis models reduced disease severity and increased natural antibodies.

Conclusions:

• SIRPα acts as a novel inhibitory receptor on B1 cells, controlling their migration.
• Modulating SIRPα signaling influences natural antibody levels and atherosclerosis progression.
• SIRPα represents a potential therapeutic target for atherosclerosis and related immune dysregulation.